Your browser doesn't support javascript.
loading
Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.
Weinbergerova, Barbora; Mayer, Jiri; Kabut, Tomas; Hrabovsky, Stepan; Prochazkova, Jirina; Kral, Zdenek; Herout, Vladimir; Pacasova, Rita; Zdrazilova-Dubska, Lenka; Husa, Petr; Bednar, Petr; Ruzek, Daniel; Lengerova, Martina.
Afiliación
  • Weinbergerova B; Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic.
  • Mayer J; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Kabut T; Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic.
  • Hrabovsky S; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Prochazkova J; Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic.
  • Kral Z; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Herout V; Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic.
  • Pacasova R; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Zdrazilova-Dubska L; Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic.
  • Husa P; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Bednar P; Department of Internal Medicine-Hematology and Oncology, Masaryk University, Brno, Czech Republic.
  • Ruzek D; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
  • Lengerova M; Department of Respiratory Diseases, Masaryk University, Brno, Czech Republic.
Hematol Oncol ; 39(5): 715-720, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34396566

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Adenosina Monofosfato / Neoplasias Hematológicas / Alanina / SARS-CoV-2 / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Hematol Oncol Año: 2021 Tipo del documento: Article País de afiliación: República Checa

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Adenosina Monofosfato / Neoplasias Hematológicas / Alanina / SARS-CoV-2 / COVID-19 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Hematol Oncol Año: 2021 Tipo del documento: Article País de afiliación: República Checa